XML 23 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common stock
Additional paid-in capital
Treasury stock at cost
Retained earnings
Accumulated other comprehensive income
Beginning balance at Dec. 31, 2018   $ 2 $ 15,716 $ (26,394) $ 16,459 $ 498
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased/forfeited   0        
Common stock and stock-based awards issued     55      
Tax withholdings related to net share settlements of restricted stock units and awards     (119)      
Stock-based compensation     260      
Common stock repurchased     0 (3,002)    
Other     (1)      
Net income $ 920       920  
Dividends and dividend equivalents declared         (254)  
Foreign currency translation adjustment           (52)
Change in unrealized gains (losses) on investments 56         56
Change in unrealized gains (losses) on derivative instruments           (30)
Tax benefit (provision) on above items           (8)
Ending balance at Jun. 30, 2019 $ 4,106 2 15,911 (29,396) 17,125 464
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.28          
Beginning balance at Mar. 31, 2019   2 15,785 (27,895) 16,847 464
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased/forfeited   0        
Common stock and stock-based awards issued     52      
Tax withholdings related to net share settlements of restricted stock units and awards     (65)      
Stock-based compensation     139      
Common stock repurchased     0 (1,501)    
Other     0      
Net income $ 402       402  
Dividends and dividend equivalents declared         (124)  
Foreign currency translation adjustment           (20)
Change in unrealized gains (losses) on investments 16         16
Change in unrealized gains (losses) on derivative instruments           11
Tax benefit (provision) on above items           (7)
Ending balance at Jun. 30, 2019 $ 4,106 2 15,911 (29,396) 17,125 464
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.14          
Beginning balance at Dec. 31, 2019 $ 2,870 2 16,126 (31,396) 17,754 384
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased/forfeited   0        
Common stock and stock-based awards issued     49      
Tax withholdings related to net share settlements of restricted stock units and awards     (83)      
Stock-based compensation     210      
Common stock repurchased (998)   (450) (3,550)    
Other     (8)      
Net income 4,158       4,158  
Dividends and dividend equivalents declared         (231)  
Foreign currency translation adjustment           (64)
Change in unrealized gains (losses) on investments 1         1
Change in unrealized gains (losses) on derivative instruments           0
Tax benefit (provision) on above items           0
Ending balance at Jun. 30, 2020 $ 2,902 2 15,844 (34,946) 21,681 321
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.32          
Beginning balance at Mar. 31, 2020   2 15,723 (34,946) 21,051 285
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased/forfeited   0        
Common stock and stock-based awards issued     45      
Tax withholdings related to net share settlements of restricted stock units and awards     (43)      
Stock-based compensation     116      
Common stock repurchased     0 0    
Other     3      
Net income $ 746       746  
Dividends and dividend equivalents declared         (116)  
Foreign currency translation adjustment           49
Change in unrealized gains (losses) on investments 32         32
Change in unrealized gains (losses) on derivative instruments           (47)
Tax benefit (provision) on above items           2
Ending balance at Jun. 30, 2020 $ 2,902 $ 2 $ 15,844 $ (34,946) $ 21,681 $ 321
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.16